Literature DB >> 3133728

Carbonic anhydrase inhibitors.

P A Preisig1, R D Toto, R J Alpern.   

Abstract

The purpose of the present review is to describe the use of carbonic anhydrase inhibitors in clinical medicine and renal physiology. We first describe the localization of carbonic anhydrase within the kidney and then discuss evidence for its role in renal acidification and NaCl absorption. This is then followed by a description of clinical uses for carbonic anhydrase inhibitors. Many of the uses and effects of carbonic anhydrase inhibitors can be predicted from an understanding of renal physiology and the role of carbonic anhydrase. The limited potency of carbonic anhydrase inhibitors correlates well with the large magnitude of carbonic anhydrase-independent bicarbonate absorption. While theories for carbonic anhydrase-independent bicarbonate absorption are presented, the exact mechanisms remain unresolved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3133728     DOI: 10.1159/000173126

Source DB:  PubMed          Journal:  Ren Physiol        ISSN: 0378-5858


  8 in total

1.  Adenylate cyclase and carbonic anhydrase in the semicircular canal epithelium of the frog Rana esculenta. An ultrastructural cytochemical localization.

Authors:  O Oudar; E Ferrary; G Feldmann
Journal:  Cell Tissue Res       Date:  1990-12       Impact factor: 5.249

2.  Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

Review 3.  [Diuretics as a problem-Pharmacokinetics, pharmacodynamics, use in edema or hypertension].

Authors:  Mark Dominik Alscher
Journal:  Internist (Berl)       Date:  2021-01-25       Impact factor: 0.743

4.  The influence of acetazolamide and amlodipine on the intracellular sodium content of rat proximal tubular cells.

Authors:  P S Wong; P L Barclay; M J Newman; E J Johns
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

5.  Adjunctive acetazolamide therapy for the treatment of Bartter syndrome.

Authors:  Mojgan Mazaheri; Farahnak Assadi; Simin Sadeghi-Bojd
Journal:  Int Urol Nephrol       Date:  2019-12-09       Impact factor: 2.370

6.  Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients.

Authors:  Nicholas Heming; Christophe Faisy; Saïk Urien
Journal:  Crit Care       Date:  2011-09-14       Impact factor: 9.097

7.  The role of acetazolamide in sleep apnea at sea level: a systematic review and meta-analysis.

Authors:  Yue-Nan Ni; Huan Yang; Robert Joseph Thomas
Journal:  J Clin Sleep Med       Date:  2021-06-01       Impact factor: 4.324

Review 8.  Mechanisms and management of edema in pediatric nephrotic syndrome.

Authors:  Mahmoud Kallash; John D Mahan
Journal:  Pediatr Nephrol       Date:  2020-11-20       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.